Business Context and Reporting Period
This Form 8-K is filed by Viewbix Inc. (not Quantum X Labs Inc., which is the target of an acquisition) for the reporting period of January 1, 2026. The filing details the entry into a material definitive agreement regarding a private placement offering and an amended acquisition strategy for Quantum X Labs Ltd.
Key Financial Metrics and Transaction Terms
- Private Placement Offering: Sale of 800,000 shares of Common Stock or Pre-Funded Warrants.
- Warrant Structure: Each share/warrant includes 80% of a Common Warrant (totaling 640,000 Common Warrants).
- Purchase Price: $1.75 per Private Placement Share (plus warrant) and $1.74999 per Pre-Funded Warrant (plus warrant).
- Expected Gross Proceeds: Approximately $1.4 million from the initial offering.
- Potential Additional Proceeds: Up to $1.68 million if all Common Warrants are exercised in cash.
- Warrant Terms:
- Pre-Funded Warrants: Exercise price of $0.00001; no expiration until fully exercised.
- Common Warrants: Exercise price of $2.625; expire five years from issuance.
- Advisory Fees: $70,000 cash fee plus a warrant for 32,000 shares payable to L.I.A. Pure Capital Ltd. upon closing.
- Debt Repayment: $200,000 of an outstanding loan to the Advisor will be repaid upon closing.
Material Changes and Strategic Context
The filing reports a material change to the original acquisition plan for Quantum X Labs Ltd. The original closing condition required the acquisition of 100% of Quantum's share capital. As of the filing date, Viewbix has only secured an agreement to acquire 85.01% of the share capital. Consequently, the terms of the private placement offering were amended to reflect this partial acquisition status.
Guidance, Risks, and Contingencies
- Closing Conditions: The offering is expected to close in Q1 2026, subject to stockholder approval (including approval for the Acquisition) and customary closing conditions.
- Registration Rights: The Company must file a resale registration statement within 30 days of closing and have it declared effective within 60 to 90 days, depending on SEC review.
- Ownership Limits: Warrant holders cannot exercise if it would result in beneficial ownership exceeding 4.99% of outstanding shares.
- Forward-Looking Risks: The filing explicitly states that closing is not guaranteed and depends on due diligence, definitive agreements, and regulatory approvals.
Investor Verification Checklist
- Verify the status of the 85.01% acquisition agreement for Quantum X Labs Ltd. and the path to acquiring the remaining 14.99%.
- Confirm the timeline for stockholder approval required for both the private placement and the acquisition.
- Review the exhibits (10.1 through 10.4) for full terms of the Purchase Agreement, Warrants, and Registration Rights.
- Assess the impact of the $200,000 debt repayment and advisory fees on the net proceeds available to the company.
- Monitor the SEC registration statement filing and effectiveness timeline post-closing.